Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.67 |
| ▸ | CA2 | P00918 | 13/20 | 0.67 |
| ▸ | CA9 | Q16790 | 12/20 | 0.67 |
| ▸ | CA12 | O43570 | 11/20 | 0.67 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.65 |
| ▸ | CA4 | P22748 | 2/20 | 0.62 |
| ▸ | CA6 | P23280 | 2/20 | 0.62 |
| ▸ | CA5A | P35218 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.62 |
| ▸ | CA3 | P07451 | 1/20 | 0.62 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.62 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.62 |
| ▸ | SOS1 | Q07889 | 3/20 | 0.61 |
| ▸ | PIM1 | P11309 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28107398 | 0.91 | SOS1 (0.70) | CA1CA2CA9CA12CA4 | |
| Diphenylamine SCHEMBL27603173 | 0.90 | CA2 (0.65) | CA1CA2CA9CA12PTPN7 | |
| Diphenylamine SCHEMBL17958823 | 0.88 | CA12 (0.67) | CA1CA2CA9CA12PTPN7 | |
| Pyrimidine SCHEMBL28325080 | 0.88 | CA1 (0.57) | CA1CA2CA9CA12PTPN7 | |
| SCHEMBL28884752 | 0.87 | CA2 (0.67) | CA1CA2CA9CA12PTPN7 | |
| SCHEMBL618161 | 0.85 | SNCA (0.71) | CA1CA2CA9CA12PTPN7 | |
| SCHEMBL28217410 | 0.85 | CA2 (0.65) | CA1CA2CA9CA12CA4 | |
| Hydrochloric Acid SCHEMBL11027004 | 0.85 | CA2 (0.65) | CA1CA2CA9CA12PTPN7 | |
| SCHEMBL671915 | 0.83 | CA2 (0.74) | CA1CA2CA9CA12CA4 | |
| SCHEMBL28746782 | 0.81 | LMNA (0.70) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118880537-A | Anti-biological adhesion warp knitting net product and preparation method thereof | 山东海工科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118546213-A | Tumor targeting polypeptide and application | 南方医科大学深圳医院 | 2024-08-27 | — | — | CN | claimed |
| US-20240174603-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | RAPPTA THERAPEUTICS OY (FI) | 2024-05-30 | — | — | US | claimed |
| CN-111912802-A | Method for detecting nitrite nitrogen by spectrophotometry | 潍坊市生态环境局寿光分局 | 2020-11-10 | — | — | CN | claimed |
| CN-110468497-A | A kind of antibacterial composite fabric and its manufacturing method | FUJIAN BAIKAI WARP KNITTING IND CO LTD | 2019-11-19 | — | — | CN | claimed |
| CN-110468463-A | A kind of high-end knitting fabric and its processing method | FUJIAN BAIKAI WARP KNITTING IND CO LTD | 2019-11-19 | — | — | CN | claimed |
| CN-110409012-A | A kind of antibiotic polyester fiber and preparation method thereof | FUJIAN BILLION POLYFIBER IND CO LTD | 2019-11-05 | — | — | CN | claimed |
| CN-110344134-A | A kind of modified polyester fibre and its production method | 福建百宏聚纤科技实业有限公司 | 2019-10-18 | — | — | CN | claimed |
| CN-107033043-B | N- replaces benzenesulfonyl-substituted benzene formyl amine compound and its prepares the purposes of drug | 中国人民解放军第二军医大学 | 2019-04-30 | — | — | CN | claimed |
| CN-107635986-A | Substituted quinoxaline derivatives | 赛尔维他股份公司 | 2018-01-26 | — | — | CN | claimed |
| CN-104419504-A | Washable machine oil | NANTONG HENGDING HEAVY MACHINE CO LTD | 2015-03-18 | — | — | CN | claimed |
| CN-101898985-B | N-substituted benzenesulfonyl-substituted benzamides small molecular inhibitor of Bcl-2 protein and application thereof | UNIV PLA 2ND MILITARY MEDICAL | 2014-05-28 | — | — | CN | claimed |
| CN-103420891-A | Triphosgene method for synthesizing benzene sulphanilamide, intermediate of glimepiride, drug for Type ii Diabetes Mellitus | NANTONG HUAFENG CHEMICAL CO | 2013-12-04 | — | — | CN | claimed |
| CN-101253221-B | A chain-end functionalized poly(ethylene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same | YOUL CHON CHEMICAL CO LTD | 2013-03-20 | — | — | CN | claimed |
| CN-102582184-A | Polyamides semi-cristallins souples | ARKEMA FRANCE | 2012-07-18 | — | — | CN | claimed |
| CN-101898985-A | N-substituted benzenesulfonyl-substituted benzamides small molecular inhibitor of Bcl-2 protein and application thereof | UNIV PLA 2ND MILITARY MEDICAL | 2010-12-01 | — | — | CN | claimed |
| CN-101253221-A | A chain-end functionalized poly(ethylene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same | YOUL CHON CHEMICAL CO LTD (KR) | 2008-08-27 | — | — | CN | claimed |
| CN-1127952-C | Anticancer medicine composition | KONG QINGZHONG (CN) | 2003-11-19 | — | — | CN | claimed |
| CN-1335839-A | Bis-sulfonamides | ACTELION PHARMACEUTICALS LTD (CH) | 2002-02-13 | — | — | CN | claimed |
| CN-1275377-A | Anticancer medicine composition | KONG QINGZHONG (CN) | 2000-12-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174603-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | PPM1A, PPP2CA, PPP3CA | CA1 1360/4885CA2 2400/4885CA9 4321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.